Adverse outcome pathway development from protein alkylation to liver fibrosis
Crossref DOI link: https://doi.org/10.1007/s00204-016-1814-8
Published Online: 2016-08-19
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Horvat, Tomislav
Landesmann, Brigitte
Lostia, Alfonso
Vinken, Mathieu
Munn, Sharon
Whelan, Maurice
Funding for this research was provided by:
Joint Research Centre
License valid from 2016-08-19